Asker Healthcare Group AB (SE:ASKER)
:ASKER
Want to see SE:ASKER full AI Analyst Report?
Total Valuation
Asker Healthcare Group AB has a market cap or net worth of kr27.44B. The enterprise value is kr33.49B.
Market Capkr27.44B
Enterprise Valuekr33.49B
Share Statistics
Asker Healthcare Group AB has 383,706,480 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding383,706,480
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Asker Healthcare Group AB’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.26%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)7.26%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee3.96M
Profits Per Employee238.08K
Employee Count4,238
Asset Turnover1.00
Inventory Turnover4.86
Valuation Ratios
The current PE Ratio of Asker Healthcare Group AB is 46.1. Asker Healthcare Group AB’s PEG ratio is 1.92.
PE Ratio46.1
PS Ratio1.85
PB Ratio4.74
Price to Fair Value4.74
Price to FCF42.11
Price to Operating Cash Flow16.73
PEG Ratio1.92
Income Statement
In the last 12 months, Asker Healthcare Group AB had revenue of 16.79B and earned 492.00M in profits. Earnings per share was 1.25.
Revenue16.79B
Gross Profit6.87B
Operating Income1.01B
Pretax Income659.00M
Net Income492.00M
EBITDA2.09B
Earnings Per Share (EPS)1.25
Cash Flow
In the last 12 months, operating cash flow was 1.64B and capital expenditures -619.00M, giving a free cash flow of 1.02B billion.
Operating Cash Flow1.64B
Free Cash Flow1.02B
Free Cash Flow per Share2.65
Dividends & Yields
Asker Healthcare Group AB pays an annual dividend of kr0.39, resulting in a dividend yield of ―
Dividend Per Sharekr0.39
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change-33.44%
50-Day Moving Average87.97
200-Day Moving Average―
Relative Strength Index (RSI)30.71
Average Volume (3m)1.96M
Important Dates
Asker Healthcare Group AB upcoming earnings date is Jul 21, 2026, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateJul 21, 2026
Ex-Dividend Date―
Financial Position
Asker Healthcare Group AB as a current ratio of 1.36, with Debt / Equity ratio of 88.07%
Current Ratio1.36
Quick Ratio0.85
Debt to Market Cap0.15
Net Debt to EBITDA2.36
Interest Coverage Ratio2.23
Taxes
In the past 12 months, Asker Healthcare Group AB has paid 149.00M in taxes.
Income Tax149.00M
Effective Tax Rate0.23
Enterprise Valuation
Asker Healthcare Group AB EV to EBITDA ratio is 17.21, with an EV/FCF ratio of 48.79.
EV to Sales2.15
EV to EBITDA17.21
EV to Free Cash Flow48.79
EV to Operating Cash Flow27.12
Balance Sheet
Asker Healthcare Group AB has kr945.00M in cash and marketable securities with kr6.02B in debt, giving a net cash position of -kr5.07B billion.
Cash & Marketable Securitieskr945.00M
Total Debtkr6.02B
Net Cash-kr5.07B
Net Cash Per Share-kr13.22
Tangible Book Value Per Share-kr7.63
Margins
Gross margin is 38.39%, with operating margin of 7.60%, and net profit margin of 2.93%.
Gross Margin38.39%
Operating Margin7.60%
Pretax Margin3.93%
Net Profit Margin2.93%
EBITDA Margin12.46%
EBIT Margin7.60%
Analyst Forecast
The average price target for Asker Healthcare Group AB is kr100.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Targetkr100.00
Price Target Upside21.58% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―